ALX Oncology (ALXO) Competitors $0.46 +0.02 (+4.49%) As of 01:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALXO vs. WHWK, SAVA, JMAC, OKYO, ENTX, IVVD, FBRX, CHRS, CLLS, and CRBPShould you be buying ALX Oncology stock or one of its competitors? The main competitors of ALX Oncology include Whitehawk Therapeutics (WHWK), Cassava Sciences (SAVA), Maxpro Capital Acquisition (JMAC), OKYO Pharma (OKYO), Entera Bio (ENTX), Invivyd (IVVD), Forte Biosciences (FBRX), Coherus Oncology (CHRS), Cellectis (CLLS), and Corbus Pharmaceuticals (CRBP). These companies are all part of the "pharmaceutical products" industry. ALX Oncology vs. Its Competitors Whitehawk Therapeutics Cassava Sciences Maxpro Capital Acquisition OKYO Pharma Entera Bio Invivyd Forte Biosciences Coherus Oncology Cellectis Corbus Pharmaceuticals ALX Oncology (NASDAQ:ALXO) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Which has more risk and volatility, ALXO or WHWK? ALX Oncology has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Which has better valuation & earnings, ALXO or WHWK? Whitehawk Therapeutics has higher revenue and earnings than ALX Oncology. ALX Oncology is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioALX OncologyN/AN/A-$134.85M-$2.47-0.19Whitehawk Therapeutics$25.98M3.61-$63.69M$0.1612.44 Is ALXO or WHWK more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to ALX Oncology's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat ALX Oncology's return on equity.Company Net Margins Return on Equity Return on Assets ALX OncologyN/A -104.43% -77.74% Whitehawk Therapeutics 99.42%-56.73%-48.68% Do institutionals and insiders believe in ALXO or WHWK? 98.0% of ALX Oncology shares are owned by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. 21.0% of ALX Oncology shares are owned by insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts prefer ALXO or WHWK? ALX Oncology presently has a consensus target price of $3.30, indicating a potential upside of 609.68%. Given ALX Oncology's stronger consensus rating and higher probable upside, research analysts plainly believe ALX Oncology is more favorable than Whitehawk Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALX Oncology 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Whitehawk Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor ALXO or WHWK? In the previous week, ALX Oncology had 1 more articles in the media than Whitehawk Therapeutics. MarketBeat recorded 1 mentions for ALX Oncology and 0 mentions for Whitehawk Therapeutics. Whitehawk Therapeutics' average media sentiment score of 0.00 beat ALX Oncology's score of -1.00 indicating that Whitehawk Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment ALX Oncology Negative Whitehawk Therapeutics Neutral SummaryWhitehawk Therapeutics beats ALX Oncology on 9 of the 15 factors compared between the two stocks. Get ALX Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALXO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALXO vs. The Competition Export to ExcelMetricALX OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.83M$2.90B$5.50B$9.01BDividend YieldN/A2.64%5.39%4.11%P/E Ratio-0.1921.5027.4220.07Price / SalesN/A282.64398.50109.13Price / CashN/A41.4736.1356.90Price / Book0.227.518.015.70Net Income-$134.85M-$55.05M$3.16B$248.47M7 Day Performance2.74%3.05%2.08%2.92%1 Month Performance-16.17%5.80%4.38%5.77%1 Year Performance-91.70%6.15%35.81%21.39% ALX Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALXOALX Oncology2.6376 of 5 stars$0.47+4.5%$3.30+609.7%-92.2%$24.83MN/A-0.1940WHWKWhitehawk TherapeuticsN/A$1.87-3.1%N/AN/A$88.10M$25.98M11.6940SAVACassava Sciences4.2092 of 5 stars$1.81+3.4%$54.50+2,911.0%-83.0%$87.44MN/A-1.2130News CoverageJMACMaxpro Capital AcquisitionN/A$6.51+1.5%N/A+2,947.6%$87.42MN/A0.002,021Gap DownOKYOOKYO Pharma1.8718 of 5 stars$2.57+4.9%$7.00+172.4%+142.5%$86.97MN/A0.007Positive NewsENTXEntera Bio2.8359 of 5 stars$1.90-4.0%$10.00+426.3%+11.7%$86.36M$223K-7.3120Positive NewsGap UpIVVDInvivyd3.2841 of 5 stars$0.72-1.6%$5.85+718.2%-34.3%$85.77M$25.38M-0.60100News CoverageGap UpFBRXForte Biosciences3.1077 of 5 stars$12.93+5.6%$61.00+371.8%+65,943.1%$85.08MN/A-0.795CHRSCoherus Oncology3.7662 of 5 stars$0.73-1.6%$4.68+540.4%-42.8%$84.78M$266.96M-0.65330Positive NewsCLLSCellectis3.0516 of 5 stars$1.53+5.2%$4.00+162.3%-12.2%$84.77M$47.63M-1.77290News CoverageCRBPCorbus Pharmaceuticals3.9189 of 5 stars$6.90-6.8%$50.88+637.3%-83.9%$84.44MN/A-1.6440Negative News Related Companies and Tools Related Companies Whitehawk Therapeutics Competitors Cassava Sciences Competitors Maxpro Capital Acquisition Competitors OKYO Pharma Competitors Entera Bio Competitors Invivyd Competitors Forte Biosciences Competitors Coherus Oncology Competitors Cellectis Competitors Corbus Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALXO) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
